1Jaffe N, Frei E 3rd, Watts H, et al. High-dose methotrexate in osteogenic sarcoma: a 5-year experience [J]. Cancer Treat Rep, 1978, 62(2) : 259 - 264.
2Rosen G, Mareove RC, Caparros B, et al. Primary osteogenic sarcoma: The rationale for preoperative chemotherapy and delayed surgery [J]. Caneer, 1979, 43(6) : 2163 -2177.
3Rosen G, Caparros B, Huvos AG, et al. Preoprative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy [ J ]. Cancer, 1982, 49 (6) : 1221 -1230.
4Meyers PA, Heller G,-Healey J, et al. -Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience [ J:. J Clin Oncol, 1992, 10(1):5-15.
5Meyers PA, Gorlick R, Heller G, et al. Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan- Kettering (T12) protocol [J]. J Clin Oncol, 1998, 16(7) : 2452 -2458.
6v Picci P, Sangiorgi L, Rougraff BT, et al. Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma [J]. J Clin Oncol, 1994, 12(12):2699-2705.
7Enneking WF. A system of staging musculoskeletal neoplasms [ J]. Clin Orthop Relat Res, 1986, 204:9 -24.
8Mankin HJ, Gebhardt MC, Jennings LC, et al. Long-term results of allograft replacement in the management of bone tumors [ J]. Clin Orthop Re- lat Res, 1996, 324:86-97.
9Mittermayer F, Krepler P, Dominkus M, et al. Long-term followup of uncemented tumor endoprostheses for the lower extremity [ J]. Clin Orthop Relat Res, 2001, 388 : 167 - 177.
10Plotz W, Rechl H, Burgkart R, et al. Limb salvage with tumor endoprostheses for malignant tumors of the knee [ J ]. Clin Orthop Relat Res, 2002, 405 : 207 -215.
